Firefly Neuroscience, Inc.
AIFF
$1.08
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.80M | 1.58M | 1.14M | 783.00K | 428.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.80M | 1.58M | 1.14M | 783.00K | 428.00K |
| Cost of Revenue | 997.00K | 761.00K | 497.00K | 267.00K | 25.00K |
| Gross Profit | 802.00K | 823.00K | 645.00K | 516.00K | 403.00K |
| SG&A Expenses | 7.86M | 7.73M | 7.72M | 7.77M | 8.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.64M | 10.08M | 9.70M | 9.50M | 10.96M |
| Operating Income | -8.84M | -8.50M | -8.56M | -8.72M | -10.53M |
| Income Before Tax | -9.11M | -8.95M | -19.88M | -21.18M | -22.83M |
| Income Tax Expenses | 1.00K | 5.00K | 5.00K | 6.00K | 6.00K |
| Earnings from Continuing Operations | -9.11 | -8.96 | -19.88 | -21.19 | -22.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.11M | -8.96M | -19.88M | -21.19M | -22.84M |
| EBIT | -8.84M | -8.50M | -8.56M | -8.72M | -10.53M |
| EBITDA | -8.68M | -8.34M | -8.42M | -8.61M | -10.46M |
| EPS Basic | -0.62 | -0.67 | -2.28 | -2.52 | -2.93 |
| Normalized Basic EPS | -0.36 | -0.39 | -1.04 | -1.14 | -1.40 |
| EPS Diluted | -0.62 | -0.67 | -2.28 | -2.52 | -2.93 |
| Normalized Diluted EPS | -0.36 | -0.39 | -1.04 | -1.14 | -1.40 |
| Average Basic Shares Outstanding | 63.92M | 56.01M | 49.73M | 44.83M | 38.41M |
| Average Diluted Shares Outstanding | 63.92M | 56.01M | 49.73M | 44.83M | 38.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |